Company Overview of Geron Bio-Med
Roslin Bio-Med develops biomedical opportunities concentrating on applications in xenotransplantation. The comapny's initial targets included the cloning of pigs by nuclear transfer and the creation of genetically modified pigs in which a key gene, alpha-1-galactosyl transferase, was eliminated. Roslin Bio-Med was founded in 1998 and is based in Scotland, U.K. Roslin Bio-Med will operate as Geron Bio-Med. As of 05/04/1999, Roslin Bio-Med is a subsidiary of Geron Corp.
Founded in 1998
Key Executives for Geron Bio-Med
Similar Private Companies By Industry
|Chroma Therapeutics Ltd.||Europe|
|NeRRe Therapeutics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Geron Bio-Med, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.